BioSpace News Archive

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immune-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today reported its financial results for the third quarter 2022 and provided a business update.

Amarin Corporation plc (NASDAQ:AMRN) today announced that Australia’s Therapeutic Good Administration (TGA) has granted approval to VAZKEPA (icosapent ethyl).

Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference in New York, NY on Wednesday, November 16, 2022 at 9:45 a.m. E.T.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that it has nearly closed out its $8 million in convertible debenture with Yorkville Advisors.

Purple Biotech Ltd. today announced that it is presenting data that provide a strong rationale for advancing CM24 as an anti-cancer, anti-metastatic agent.

MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Bio-Techne Corporation announced the opening of its new 52,000 square foot state-of-the-art product innovation and manufacturing facility.

HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company developing innovative medicines, today reported financial results for the third quarter of 2022 and provided recent business updates.

Daewoong Pharmaceutical Co., Ltd. (CEO Jeon Sengho, Lee Changjae) announced the third-quarter financial results.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today reported third quarter financial results and recent corporate and portfolio updates.